About BioResponse Nutrients, LLC

BioResponse Nutrients LLC is the originator of microencapsulated BioResponse Diindolylmethane (BioResponse DIM). The company engages in the research, development, manufacturing and distributing of patented dietary ingredients to companies worldwide under signed licensing agreements and directly to health care providers and consumers.

BioResponse’s mission for the last 10 years has been its commitment to research for present nutraceutical and future therapeutic uses of DIM. The National Cancer Institute has recently renewed its Clinical Trials Agreement with BioResponse to further study this microencapsulated absorbable form of DIM in numerous clinical protocols.

Michael A. Zeligs, M.D., CEO and Founder, was the first ever to develop absorbable diindolylmethane (DIM) for human use. DIM, a natural indole discovered in cruciferous vegetables, is highly insoluble. In collaboration with co-inventor Irwin C Jacobs, Ph.D and other world-renowned scientists, BioResponse developed the only patented microencapsulation technology that guarantees the absorption of DIM. This innovative technology significantly improves the absorption of DIM. BioResponse has received numerous U.S. and world patents for uses of DIM for women's and men's health.

BioResponse DIM is the dietary ingredient of choice, backed by scientific studies. Improved Estrogen Metabolism, Breast, Uterine, Cervical, and Prostate Health are all under clinical study using microencapsulated DIM at numerous universities worldwide.

LEARN MORE: About Michael A. Zeligs, M.D.